| Why is research on amyloid-β failing to give new drugs for Alzheimer’s disease? AJ Doig, MP del Castillo-Frias, O Berthoumieu, B Tarus, ... ACS chemical neuroscience 8 (7), 1435-1437, 2017 | 205 | 2017 |
| Combined Experimental and Simulation Studies Suggest a Revised Mode of Action of the Anti‐Alzheimer Disease Drug NQ‐Trp O Berthoumieu, PH Nguyen, MP Castillo‐Frias, S Ferre, B Tarus, ... Chemistry–A European Journal 21 (36), 12657-12666, 2015 | 23 | 2015 |
| Amyloid-β/drug interactions from computer simulations and cell-based assays PH Nguyen, MP del Castillo-Frias, O Berthoumieux, P Faller, AJ Doig, ... Journal of Alzheimer's Disease 64 (s1), S659-S672, 2018 | 6 | 2018 |
| Drug repositioning strategies for rare and orphan diseases: A cost-effective approach for new uses for existing drugs MP del Castillo-Frias, AJ Doig, F Khan Rare Diseases, 114-149, 2017 | | 2017 |
| Drug Candidates for Repositioning in Alzheimer’s Disease MP del Castillo-Frias, AJ Doig Drug Repositioning, 201-220, 2017 | | 2017 |
| 11 Drug Candidates MP del Castillo-Frias, AJ Doig Drug Repositioning: Approaches and Applications for Neurotherapeutics, 201, 2017 | | 2017 |
| Optimisation and use of cell-based assays and in vivo assay for screening drugs for Alzheimer's Disease MP del Castillo Frias University of Manchester, 2017 | | 2017 |
